Showing results (121-130 of 1,917) with videos related to
Sort By:
Pageof 192
CNS & Neurological Disorders Drug Targets|August 9, 2021
Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal ExposureAmit Raj Sharma, Gitika Batra, Lokesh Saini, et al.CNS & Neurological Disorders Drug Targets|August 9, 2021
Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's DiseaseYi Wang, Gary A DykesCNS & Neurological Disorders Drug Targets|August 26, 2022
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental HealthNirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, et al.CNS & Neurological Disorders Drug Targets|May 27, 2020
The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's DiseaseHirak Shah, Ashish Patel, Vruti Parikh, et al.CNS & Neurological Disorders Drug Targets|June 14, 2020
MAPK: A Key Player in the Development and Progression of StrokeYangmin Zheng, Ziping Han, Haiping Zhao, et al.CNS & Neurological Disorders Drug Targets|April 14, 2006
The involvement of the vasopressin system in stress-related disordersRainer LandgrafCNS & Neurological Disorders Drug Targets|June 22, 2006
G protein-coupled receptors in regulation of body weightHelgi B SchiöthCNS & Neurological Disorders Drug Targets|June 22, 2006
NPY receptors as drug targets for the central regulation of body weightMichel Félétou, Jean-Pierre Galizzi, Nigel R LevensCNS & Neurological Disorders Drug Targets|June 22, 2006
Growth hormone secretagogue (ghrelin-) receptors--a complex drug target for the regulation of body weightR Nogueiras, D Perez-Tilve, K E Wortley, et al.CNS & Neurological Disorders Drug Targets|August 22, 2006
Molecular pathologies of and enzyme replacement therapies for lysosomal diseasesHitoshi Sakuraba, Makoto Sawada, Fumiko Matsuzawa, et al.Pageof 192